Cargando…
OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
Providing the optimal dosing strategy of a drug for an individual patient is an important task in pharmaceutical sciences and daily clinical application. We developed and validated an optimal dosing algorithm (OptiDose) that computes the optimal individualized dosing regimen for pharmacokinetic–phar...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550736/ https://www.ncbi.nlm.nih.gov/pubmed/34720180 http://dx.doi.org/10.1007/s10957-021-01819-w |
_version_ | 1784591019365367808 |
---|---|
author | Bachmann, Freya Koch, Gilbert Pfister, Marc Szinnai, Gabor Schropp, Johannes |
author_facet | Bachmann, Freya Koch, Gilbert Pfister, Marc Szinnai, Gabor Schropp, Johannes |
author_sort | Bachmann, Freya |
collection | PubMed |
description | Providing the optimal dosing strategy of a drug for an individual patient is an important task in pharmaceutical sciences and daily clinical application. We developed and validated an optimal dosing algorithm (OptiDose) that computes the optimal individualized dosing regimen for pharmacokinetic–pharmacodynamic models in substantially different scenarios with various routes of administration by solving an optimal control problem. The aim is to compute a control that brings the underlying system as closely as possible to a desired reference function by minimizing a cost functional. In pharmacokinetic–pharmacodynamic modeling, the controls are the administered doses and the reference function can be the disease progression. Drug administration at certain time points provides a finite number of discrete controls, the drug doses, determining the drug concentration and its effect on the disease progression. Consequently, rewriting the cost functional gives a finite-dimensional optimal control problem depending only on the doses. Adjoint techniques allow to compute the gradient of the cost functional efficiently. This admits to solve the optimal control problem with robust algorithms such as quasi-Newton methods from finite-dimensional optimization. OptiDose is applied to three relevant but substantially different pharmacokinetic–pharmacodynamic examples. |
format | Online Article Text |
id | pubmed-8550736 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-85507362021-10-29 OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control Bachmann, Freya Koch, Gilbert Pfister, Marc Szinnai, Gabor Schropp, Johannes J Optim Theory Appl Article Providing the optimal dosing strategy of a drug for an individual patient is an important task in pharmaceutical sciences and daily clinical application. We developed and validated an optimal dosing algorithm (OptiDose) that computes the optimal individualized dosing regimen for pharmacokinetic–pharmacodynamic models in substantially different scenarios with various routes of administration by solving an optimal control problem. The aim is to compute a control that brings the underlying system as closely as possible to a desired reference function by minimizing a cost functional. In pharmacokinetic–pharmacodynamic modeling, the controls are the administered doses and the reference function can be the disease progression. Drug administration at certain time points provides a finite number of discrete controls, the drug doses, determining the drug concentration and its effect on the disease progression. Consequently, rewriting the cost functional gives a finite-dimensional optimal control problem depending only on the doses. Adjoint techniques allow to compute the gradient of the cost functional efficiently. This admits to solve the optimal control problem with robust algorithms such as quasi-Newton methods from finite-dimensional optimization. OptiDose is applied to three relevant but substantially different pharmacokinetic–pharmacodynamic examples. Springer US 2021-02-24 2021 /pmc/articles/PMC8550736/ /pubmed/34720180 http://dx.doi.org/10.1007/s10957-021-01819-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Bachmann, Freya Koch, Gilbert Pfister, Marc Szinnai, Gabor Schropp, Johannes OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control |
title | OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control |
title_full | OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control |
title_fullStr | OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control |
title_full_unstemmed | OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control |
title_short | OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control |
title_sort | optidose: computing the individualized optimal drug dosing regimen using optimal control |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550736/ https://www.ncbi.nlm.nih.gov/pubmed/34720180 http://dx.doi.org/10.1007/s10957-021-01819-w |
work_keys_str_mv | AT bachmannfreya optidosecomputingtheindividualizedoptimaldrugdosingregimenusingoptimalcontrol AT kochgilbert optidosecomputingtheindividualizedoptimaldrugdosingregimenusingoptimalcontrol AT pfistermarc optidosecomputingtheindividualizedoptimaldrugdosingregimenusingoptimalcontrol AT szinnaigabor optidosecomputingtheindividualizedoptimaldrugdosingregimenusingoptimalcontrol AT schroppjohannes optidosecomputingtheindividualizedoptimaldrugdosingregimenusingoptimalcontrol |